Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hugobiotech is a leading Chinese biotechnology company specializing in microbial metagenomic next-generation sequencing for pathogen detection. Its PACEseq platform integrates AI with high-throughput sequencing to deliver rapid, accurate pathogen identification with an >85% accordance rate. The company serves over 800 top-tier hospitals in China and has tested the world’s largest number of CSF samples by mNGS. It is also involved in global health initiatives such as TB diagnostics optimization supported by the Gates Foundation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hugobiotech.